ALZHEIMER'S DISEASE PSYCHOSIS
Clinical trials for ALZHEIMER'S DISEASE PSYCHOSIS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE PSYCHOSIS trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial targets terrifying hallucinations in Alzheimer's patients
Disease control Recruiting nowThis research tests whether the experimental drug ACP-204 can reduce distressing hallucinations and delusions in people with Alzheimer's disease. The study involves over 1,000 adults aged 55-95 who experience these psychotic symptoms. Participants will receive either the drug or …
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE2, PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New pill tested for serious mental health conditions
Disease control Recruiting nowThis early-stage study is testing a new extended-release pill called LY03020 to see if it's safe and how it moves through the body. It will involve 40 Chinese adults, including both healthy volunteers and people with stable schizophrenia. Researchers will give different doses to …
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC